Shaily Engineering Plastics profit surges 46%, healthcare revenue jumps 85%

2 min read     Updated on 08 Aug 2026, 07:19 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Shaily Engineering Plastics posted strong Q1FY27 results with standalone PAT up 46% to ₹52.47 crore and consolidated revenue rising 14% to ₹280.7 crore. Healthcare revenue surged 85% due to new drug delivery device projects, offsetting a 24% decline in the consumer segment. Operational efficiency improved with EBITDA margins expanding 120 bps to 29.7%.

powered bylight_fuzz_icon
47741908

*this image is generated using AI for illustrative purposes only.

Shaily Engineering Plastics delivered a robust financial performance in Q1FY27, with standalone net profit after tax (PAT) surging 46% year-on-year to ₹52.47 crore. The strong bottom-line growth was underpinned by an 85% surge in healthcare segment revenue to ₹142.4 crore, which offset a 24% decline in consumer demand. Consolidated EBITDA margins expanded by 120 basis points (bps) to 29.7%, reflecting improved operational efficiency and higher machine utilization across its Gujarat facilities.

The Board of Directors approved the unaudited financial results on August 08, 2026, in compliance with Regulation 33 of the SEBI Listing Regulations, 2015. Statutory auditors B S R and Co. issued an unmodified limited review report. The company also released its Q1 & FY27 Investor Presentation, highlighting new business confirmations in semaglutide pens supply for Canada and Brazil, as well as projects from FMCG and automotive clients.

Financial Performance Highlights

Consolidated revenue from operations rose 14% YoY to ₹280.7 crore. While standalone PAT jumped 46%, consolidated PAT grew 17% to ₹48.0 crore, indicating that subsidiary performance diluted the overall growth rate slightly. Cash PAT, defined as PAT plus depreciation, increased 18% to ₹62.1 crore.

Metric Standalone Q1FY27 Standalone Q1FY26 Change Consolidated Q1FY27 Consolidated Q1FY26 Change
Revenue from Operations ₹274.78 cr ₹225.10 cr +22% ₹280.7 cr ₹246.7 cr +14%
Net Profit After Tax ₹52.47 cr ₹35.97 cr +46% ₹48.0 cr ₹41.1 cr +17%
EBITDA Margin 29.7% 28.5% +120 bps
Gross Profit Margin 56.6% 51.2% +540 bps

Segment-Wise Revenue Breakdown

The healthcare segment emerged as the primary growth driver, with revenue rising 85% to ₹142.4 crore from ₹77.2 crore in Q1FY26. This growth was fueled by customer approvals for semaglutide pen supplies and two new IP-led platform projects. Conversely, the consumer segment faced weaker market demand in Europe and the USA, leading to a 24% revenue drop to ₹115.5 crore. The industrial segment grew 25% to ₹22.7 crore, supported by new projects in appliances, consumer electronics, and automotive components.

What the Numbers Show

The divergence between standalone and consolidated profitability highlights the impact of subsidiary operations. While the parent entity achieved a 46% PAT surge, consolidated PAT grew only 17%. This suggests that subsidiaries, including Shaily Innovations Ltd and Shaily Innovations FZCO, contributed less proportionally to bottom-line growth. Notably, one subsidiary reported a net loss of ₹1.97 crore, which was deemed immaterial but diluted aggregate profit expansion. However, the group’s overall health remains strong, with Return on Capital Employed (RoCE) improving by 320 bps to 39.0% and Total Debt/Equity ratio decreasing from 0.3 to 0.2.

Historical Stock Returns for Shaily Engineering Plastics

1 Day5 Days1 Month6 Months1 Year5 Years
-6.06%+4.40%+9.98%+57.32%+91.01%+683.33%

How will the new semaglutide pen supply contracts in Canada and Brazil impact Shaily's revenue mix and margin profile over the next 12-18 months?

What specific strategies is management implementing to reverse the 24% decline in the consumer segment amid weakening demand in Europe and the USA?

Will the improved operational efficiency and machine utilization at Gujarat facilities be sustainable as the company scales up production for new healthcare projects?

Shaily Engineering Plastics
View Company Insights
View All News
like18
dislike

Shaily Engineering Plastics hosts Q1 earnings call on Aug 10

1 min read     Updated on 03 Aug 2026, 04:39 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Shaily Engineering Plastics Limited announced an earnings call for August 10, 2026, to review Q1FY27 performance. Managed by Strategic Growth Advisors, the session features MD Amit Sanghvi and CSO Sanjay Shah. Dial-in numbers are available for India, US, UK, Singapore, and Hong Kong.

powered bylight_fuzz_icon
47300924

*this image is generated using AI for illustrative purposes only.

Shaily Engineering Plastics Limited will host an earnings conference call on August 10, 2026, at 4:00 PM IST to discuss its operational and financial performance for the quarter ended June 30, 2026. The meeting provides investors and analysts with a direct channel to review the company’s Q1FY27 results and strategic outlook. Participation details and registration links have been made available on the company’s investor relations website.

The announcement was filed with the Bombay Stock Exchange and the National Stock Exchange of India Limited in compliance with Regulation 30 of the SEBI Listing Regulations, 2015. Harish Punwani, Company Secretary & Compliance Officer, issued the intimation on August 3, 2026. The filing confirms that the earnings call invite is also hosted on the company’s official website for broader accessibility.

Key Participants and Access Details

The conference call will be led by senior management, including Amit Sanghvi, Managing Director, and Sanjay Shah, Chief Strategy Officer. Strategic Growth Advisors Pvt. Ltd. has been appointed to manage the event logistics and participant registration. Investors can register via the pre-registration link provided in the official communication.

Region Dial-In Number
Universal (India) +91 22 6280 1309 / +91 22 7115 8210
United States 1 866 746 2133
United Kingdom 0 808 101 1573
Singapore 800 101 2045
Hong Kong 800 964 448

For international participants, the call timing corresponds to 6:30 PM in Hong Kong and Singapore, 11:30 AM in the UK, and 6:30 AM EST in the USA. RSVPs should be directed to Deven Dhruva or Krisha Shrimankar at Strategic Growth Advisors Pvt. Ltd.

What This Means for Investors

While the specific financial metrics for Q1FY27 are not detailed in this preliminary notice, the earnings call serves as a critical disclosure mechanism for market participants. The discussion will likely address revenue trends, margin dynamics, and capital allocation strategies for the engineering plastics sector. Investors are advised to prepare questions regarding operational efficiencies and demand visibility ahead of the scheduled briefing.

Historical Stock Returns for Shaily Engineering Plastics

1 Day5 Days1 Month6 Months1 Year5 Years
-6.06%+4.40%+9.98%+57.32%+91.01%+683.33%

How might Shaily Engineering Plastics' Q1FY27 margin performance reflect broader supply chain pressures or raw material cost trends in the engineering plastics sector?

What specific strategic initiatives did Sanjay Shah outline for driving growth in high-value end-use markets such as automotive or electronics during the call?

Will management provide updated guidance for FY27 full-year revenue and EBITDA, particularly regarding demand visibility in international markets?

Shaily Engineering Plastics
View Company Insights
View All News
like15
dislike

More News on Shaily Engineering Plastics

1 Year Returns:+91.01%